Networking +
Policy +
Member
Career
Choose
Weekly Policy Update: CMS Proposed Rule is a Step Forward for the Coverage of Breakthrough Technologies
By: Colorado BioScience Association Date: 05/13/2019
In late April, the Centers for Medicare and Medicaid Services (CMS) publicly released its FY 2020 Inpatient Prospective Payment System (IPPS) Proposed Rule. The rule is a critical step forward for cov...
Learn MoreWeekly Policy Update: The Final Tally - 2019 Legislative Session Comes to a Close
By: Colorado BioScience Association Date: 05/03/2019
CBSA has worked hard this session to advocate on behalf of the industry. We’ve worked with our members and partners to advance proposals that promote patient safety, protect patient access, and enhanc...
Learn MoreWeekly Policy Update: One Week Left - What Will Make It Across the Finish Line
By: Colorado BioScience Association Date: 04/26/2019
With just over a week left in the 2019 legislative session, there are hundreds of bills left to debate and Democrats are scrambling to get their remaining priorities across the finish line. Here are s...
Learn MoreCBSA Opposes Drug Importation and Continues to Advocate for Safe Policy to Reduce Patient Costs
By: Colorado BioScience Association Date: 04/22/2019
Last week CBSA testified in the House Health and Insurance Committee in opposition to Senate Bill 005 - Import Prescription Drugs From Canada, which would require the Department of Health Care Policy...
Learn MoreWeekly Policy Update: CBSA Applauds Introduction of House Bill to Permanently Repeal Medical Device Excise Tax
By: Colorado BioScience Association Date: 04/12/2019
This week bipartisan legislation was introduced in the U.S. House of Representatives to permanently repeal the medical device excise tax. CBSA applauds the introduction of H.R. 2207, Protect Medical I...
Learn MoreWeekly Policy Update: Drug Pricing Transparency Bill Introduced in Colorado, Plus CBSA Advocates in DC
By: Colorado BioScience Association Date: 04/05/2019
This week CBSA testified in the House Health and Insurance Committee in opposition to House Bill 1296 – Prescription Drug Cost Reduction Measures. The bill requires health insurers, prescription drug...
Learn MoreCBSA and BIO Honor Colorado Congressional Leaders as Innovators in Biotechnology
By: Colorado BioScience Association Date: 04/04/2019
Senator Michael Bennet, Congresswoman Diana DeGette Recognized as Champions of Life Science Washington, D.C. (April 4, 2019) – Colorado BioScience Association and Biotechnology Innovation Organization...
Learn MoreWeekly Policy Update: CBSA Raises Concerns about Importing Drugs From Canada, Plus A Full Review of this Month In Policy
By: Colorado BioScience Association Date: 04/01/2019
This week President & CEO Jennifer Jones Paton spoke with 630 KHOW’s Krista Kafer about CBSA’s opposition to Senate Bill 5, which would create a Canadian drug importation program in Colorado. Thro...
Learn MoreWeekly Policy Update: Colorado State Budget and Forecast, Plus CBSA Voices Concerns on Drug Pricing Legislation
By: Colorado BioScience Association Date: 03/22/2019
Last week the non-partisan Legislative Council published the forecast for the economy and state government revenue through FY 2019-20. The forecast showed that while the economy will continue to grow...
Learn MoreWeekly Policy Update: Family Medical Leave Insurance Program and the President's Proposed Budget
By: Colorado BioScience Association Date: 03/15/2019
On Wednesday Senate Bill 188, FAMLI Family Medical Leave Insurance Program, was heard and passed out of the Senate Committee on Business, Labor & Technology. The bill would create a state-run fami...
Learn More